头孢比普对耐甲氧西林金黄色葡萄球菌（MRSA）、万古霉素中介金黄色葡萄球菌（VISA）、万古霉素耐药金黄色葡萄球菌（VRSA）及达托霉素不敏感金黄色葡萄球菌（DNSSA）的体外活性。 - Suppr | 超能文献

In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).

作者信息

Saravolatz Louis D, Pawlak Joan, Johnson Leonard B, Saravolatz Louis D, Husain Nasir

出版信息

Int J Antimicrob Agents. 2010 Nov;36(5):478-80. doi: 10.1016/j.ijantimicag.2010.07.016. Epub 2010 Sep 16.

DOI:10.1016/j.ijantimicag.2010.07.016

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).头孢比普对耐甲氧西林金黄色葡萄球菌（MRSA）、万古霉素中介金黄色葡萄球菌（VISA）、万古霉素耐药金黄色葡萄球菌（VRSA）及达托霉素不敏感金黄色葡萄球菌（DNSSA）的体外活性。

Int J Antimicrob Agents. 2010 Nov;36(5):478-80. doi: 10.1016/j.ijantimicag.2010.07.016. Epub 2010 Sep 16.

2

In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).体外研究奥塔万古霉素对社区获得性耐甲氧西林金黄色葡萄球菌（CA-MRSA）、万古霉素中介金黄色葡萄球菌（VISA）、万古霉素耐药金黄色葡萄球菌（VRSA）和达托霉素不敏感金黄色葡萄球菌（DNSSA）的活性。

Int J Antimicrob Agents. 2010 Jul;36(1):69-72. doi: 10.1016/j.ijantimicag.2010.02.023. Epub 2010 Apr 21.

3

Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.使用体外模型比较头孢比普与万古霉素对耐甲氧西林金黄色葡萄球菌（MRSA）、万古霉素中介金黄色葡萄球菌（VISA）和耐万古霉素金黄色葡萄球菌（VRSA）的药效学活性。

J Antimicrob Chemother. 2009 Aug;64(2):364-9. doi: 10.1093/jac/dkp176. Epub 2009 May 19.

4

In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals.一项对比利时医院全国性调查中分离出的耐甲氧西林金黄色葡萄球菌菌株，头孢比普、替加环素、达托霉素及其他19种抗菌药物的体外活性研究

Antimicrob Agents Chemother. 2006 Aug;50(8):2680-5. doi: 10.1128/AAC.00272-06.

5

Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.在耐甲氧西林金黄色葡萄球菌菌血症和骨髓炎治疗期间出现临床耐达托霉素金黄色葡萄球菌分离株。

J Clin Microbiol. 2006 Feb;44(2):595-7. doi: 10.1128/JCM.44.2.595-597.2006.

6

Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.万古霉素中介金黄色葡萄球菌（VISA）和异质性万古霉素中介金黄色葡萄球菌（hVISA）中的达托霉素不敏感性：万古霉素治疗失败后治疗的影响。

J Antimicrob Chemother. 2011 May;66(5):1057-60. doi: 10.1093/jac/dkr066. Epub 2011 Mar 2.

7

In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates.耐万古霉素中间型和耐万古霉素金黄色葡萄球菌分离株的体外药敏试验和分子分析。

Clin Infect Dis. 2012 Aug;55(4):582-6. doi: 10.1093/cid/cis492. Epub 2012 May 21.

8

Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.头孢洛林对耐甲氧西林金黄色葡萄球菌（MRSA）中达托霉素、利奈唑胺或万古霉素低水平耐药株，以及具有明确 SCCmec 型别的菌株的活性。

Int J Antimicrob Agents. 2014 Apr;43(4):323-7. doi: 10.1016/j.ijantimicag.2013.11.005. Epub 2013 Dec 11.

9

Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.万古霉素和达托霉素对 29 年来分离的金黄色葡萄球菌的疗效。

Diagn Microbiol Infect Dis. 2010 Apr;66(4):441-4. doi: 10.1016/j.diagmicrobio.2009.11.008.

10

Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.台湾地区一株对达托霉素不敏感、对万古霉素中介且耐甲氧西林的金黄色葡萄球菌引起的菌血症和感染性心内膜炎

J Clin Microbiol. 2008 Mar;46(3):1132-6. doi: 10.1128/JCM.01844-07. Epub 2008 Jan 16.

引用本文的文献

1

Genetic Characterization of Methicillin Resistant and Sensitive, Vancomycin Intermediate Staphylococcus aureus Strains Isolated from Different Iranian Hospitals.从不同伊朗医院分离出的耐甲氧西林和敏感、万古霉素中介金黄色葡萄球菌菌株的基因特征分析

ISRN Microbiol. 2012 Dec 20;2012:215275. doi: 10.5402/2012/215275. Print 2012.

2

In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.头孢洛林与万古霉素治疗耐万古霉素中间葡萄球菌实验性心内膜炎的体内协同作用。

Antimicrob Agents Chemother. 2011 Sep;55(9):3977-84. doi: 10.1128/AAC.00402-11. Epub 2011 Jul 5.